Differential CXC receptor expression in colorectal carcinomas

Scandinavian Journal of Immunology

Volumn 68, Issue 6, 2008, Pages 635-644

  Rubie, C ^a,b   Kollmar, O ^b   Frick, V O ^b   Wagner, M ^b   Brittner, B ^b   Graber S ^b   Schilling, M K ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADENOMA; ADULT; AGED; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, CXCR; RNA, NEOPLASM;

EID: 55349101672     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02163.x     Document Type: Article

References (44)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000 50 : 7 33.
2. McLeod HL, McKay JA, Collie-Duguid ES, Cassidy J. Therapeutic opportunities from tumor biology in metastatic colon cancer. Eur J Cancer 2000 36 : 1706 12.
3. Booth RA. Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 2007 249 : 87 96.
4. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 2006 13 : 191 9.
5. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000 18 : 217 42.
6. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000 12 : 121 7.
7. Strieter RM, Polverini PJ, Kunkel SL et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995 270 : 27348 57.
8. Smith DR, Polverini PJ, Kunkel SL et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994 179 : 1409 15.
9. Arenberg DA, Keane MP, DiGiovine B et al. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998 102 : 465 72.
10. + CXC chemokine-induced angiogeneic activity. J Immunol 2000 165 : 5269 77.
11. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and Mig: structure, function and expression in activated T-lymphocytes. J Exp Med 1996 184 : 963 9.
12. Yang J, Richmond A. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Mol Ther 2004 9 : 846 55.
13. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001 410 : 50 6.
14. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strietew RM. The stromal derived factor -1 /CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung metastases. Am J Respir Crit Care Med 2003 167 : 1667 86.
15. Singh S, Malik BK, Sharma DK. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development. Chem Biol Drug Des 2007 69 : 191 203.
16. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003 63 : 3833 9.
17. Rubie C, Oliveira V, Kempf K et al. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 2006 27 : 166 74.
18. Rubie C, Oliveira Frick V, Wagner M et al. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol 2006 41 : 6627 33.
19. UICC. TNM Classification of Malignant Tumors, 5th edn. New York : Wiley-Liss, 1997.
20. Bustin SA. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000 25 : 169 93.
21. Rubie C, Kempf K, Hans J et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005 19 : 101 9.
22. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comp Meth Pro Biomed 1995 48 : 257 62.
23. Kollmar O, Scheuer C, Menger MD, Schilling MK. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration and tumor growth in hepatic metastasis. Ann Surg Oncol 2006 13 : 263 75.
24. Kollmar O, Junker B, Rupertus K, Menger MD, Schilling MK. Studies on MIP-2 and CXCR2 expression in a mouse model of extrahepatic colorectal metastasis. Eur J Surg Oncol 2007 33 : 803 11.
25. Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006 42 : 768 78.
26. Moore BB, Arenberg DA, Addison CL, Keane MP, Polverini PJ, Strieter RM. CXC chemokines mechanism of action in regulating tumor angiogenesis. Angiogenesis 1998 2 : 123 34.
27. + CXC chemokines. Chest 2004 125 : 133S.
28. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 2004 172 : 2853 60.
29. Wente MN, Keane MP, Burdick MD et al. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 2006 241 : 221 7.
30. Li A, Varnea ML, Singh RK. Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatc phenotype. Clin Exp Metastasis 2004 21 : 571 9.
31. Cella M, Jarrossay D, Facchetti F et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999 5 : 919 23.
32. Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004 5 : 1260 5.
33. Romagnani P, Annunziato F, Lasagni L et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001 107 : 53 63.
34. Robledo MM, Barolom RA, Longo N et al. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001 276 : 45098 105.
35. Kawada K, Sonoshita M, Sakashita H et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 2004 64 : 4010 7.
36. Kawada K, Hosogi H, Sonoschita H et al. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 2007 26 : 4679 88.
37. Schrader AJ, Lechner O, Templin M et al. CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 2002 86 : 1250 6.
38. Koshiba T, Hosotani R, Miyamoto Y et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000 6 : 3530 5.
39. Hwang JH, Chung HK, Kim DW et al. CXC receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2003 88 : 408 16.
40. Eisenhardt A, Frey U, Tack M et al. Expression analysis and potential functional role of the cxcr4 chemokine receptor in bladder cancer. Eur Urol 2005 47 : 111 7.
41. Geminder H, Sagi-Assif O, Goldberg L et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1 in the development of bone marrow metatases in neuroblastoma. J Immunol 2001 167 : 4747 57.
42. Bertolini F, Dell'Agnola C, Mancuso P et al. CXCR4 neutralization, a novel therapeutic approach for Non-Hodgkin's lymphoma. Cancer Res 2002 62 : 3106 12.
43. Kim J, Takeuchi H, Lam ST et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005 23 : 2744 53.
44. Rubie C, Frick VO, Wagner M et al. Enhanced expression and clinical significance of CC-chemokine MIP-3alpha in hepatocellular carcinoma. Scand J Immunol 2006 63 : 468 77.